Inventors with similar research interests:
Location History:
- Richmond, CA (US) (1998 - 1999)
- Danville, CA (US) (1995 - 2014)
Company Filing History:
48 out of 100 
14 out of 1,384 
6 out of 52 
Years Active: 1995-2014
Areas of Expertise:
Title: Michael M. Morrissey: Innovations in TGR5 Agonists
Introduction
Michael M. Morrissey, an accomplished inventor based in Danville, California, holds an impressive portfolio of 73 patents. His work focuses primarily on TGR5 agonists, which have significant implications in the treatment of diabetes and obesity. Morrissey's innovative contributions to the field have made him a noteworthy figure in pharmaceutical research and development.
Latest Patents
Morrissey's latest patents include novel TGR5 agonists characterized by specific structural formulas. One notable patent involves TGR5 agonists of structural formula VIII(Q), where X, R, R, and R are defined within the specification. These compounds, along with their pharmaceutically acceptable salts, compositions, and usage in treating various diseases, showcase the potential of his research.
Another significant patent features triazole and imidazole derivatives designed as TGR5 agonists for treating diabetes and obesity. This invention encompasses TGR5 agonists of structural formula I, N-oxides of these compounds, and their acceptable salts. The enhanced compositions and their medical applications further underline Morrissey's commitment to addressing serious health concerns.
Career Highlights
Throughout his career, Morrissey has contributed to advancing pharmaceutical science while working with renowned companies, including Berlex Laboratories, Inc. and Schering Aktiengesellschaft. These positions allowed him to collaborate with leading professionals and engage in cutting-edge research that bolstered his patents and innovations.
Collaborations
Morrissey has worked alongside notable colleagues such as Howard P. Ng and Brad Owen Buckman. These collaborations have likely played a vital role in furthering his research and product development, promoting a shared vision to expand the therapeutic potential of TGR5 agonists.
Conclusion
Michael M. Morrissey's innovative work in the realm of TGR5 agonists exemplifies the impactful relationship between inventors and the advancement of medical treatments. With a substantial number of patents and a history of collaboration with esteemed colleagues and companies, Morrissey continues to contribute to important breakthroughs in pharmaceutical science. His journey serves as an inspiration for future inventors seeking to make a difference in healthcare.